Sustained release formulations using non-aqueous carriers

The disclosure relates to a manufactured pre-mixed formulation for injection consisting essentially of a suspension of: (i) a pharmaceutically acceptable non-aqueous carrier which consists essentially of one or more triglycerides of C6-C12 fatty acids; and (ii) microspheres which consist essentially...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HOUCHIN MARY L, LEE ROBIN H, QI HONG, JENNINGS ROBERT N, COLEMAN SCOTT H, OEHRTMAN GREG
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The disclosure relates to a manufactured pre-mixed formulation for injection consisting essentially of a suspension of: (i) a pharmaceutically acceptable non-aqueous carrier which consists essentially of one or more triglycerides of C6-C12 fatty acids; and (ii) microspheres which consist essentially of a poly(lactide-co-glycolide) polymer having dispersed therein about 5% (w/w) exenatide as active pharmaceutical ingredient and about 2% (w/w) sucrose; wherein the ratio of lactide:glycolide in the polymer is about 1:1.